FDA: Urgent Correction for Baxter Volara System
Baxter issued an Urgent Medical Device Correction notice for all Volara System patient circuits to be corrected prior to continued use, according to an FDA alert.
Baxter issued an Urgent Medical Device Correction notice for all Volara System patient circuits to be corrected prior to continued use, according to an FDA alert.
Baxter issued an Urgent Medical Device Correction notice for all Volara System patient circuits to be corrected prior to continued use, according to an FDA alert.
Read MoreA new two-year pilot program from Baxter Foundation and Pet Partners aims to increase access to therapy animal programs in healthcare settings across the country.
Read MoreThe Vest APX System utilizes high frequency chest wall oscillation to mobilize secretions and reduce pulmonary exacerbations for patients with chronic respiratory conditions.
Read MoreThe Volara Airway Clearance System combines oscillation and lung expansion therapy with aerosol...
Read MoreThe Synclara Cough System uses mechanical technology to help patients with weak coughs clear their airways and reduce infection risks.
Read MoreBaxter is recalling the Life2000 Ventilation System due to a cybersecurity issue discovered through internal testing, the FDA reports.
Read MoreBaxter’s Welch Allyn Connex 360 Vital Signs Monitor received FDA 510(k) clearance and is now available for US hospitals and health systems, according to the company.
Read MoreA closer look at suction and secretion clearance devices from ABM Respiratory, Baxter, Neotech, Philips, Precision Medical, Sentec, Seoil Pacific, and Tactile Medical.
Read MoreBaxter’s Voalte Linq powered by Scotty assistant, is a lightweight, voice-activated wearable badge designed to support efficient hospital communication between care teams and allow them to focus on direct patient care.
Read MoreBaxter announced the immediate retirement of CEO Joe Almeida, with Brent Shafer appointed as chair and interim CEO.
Read MoreBaxter is replacing faulty battery chargers in the Life2000 Ventilator system after identifying a defect that triggers alarms and renders the device inoperable.
Read MoreBaxter Healthcare has issued a correction for the Life2000 ventilator due to a potential alarm failure, with a software update forthcoming to address the issue.
Read MoreNew guidance provides hospitals with strategies to mitigate the impact of IV fluid shortages caused by recent hurricane-related disruptions in key manufacturing facilities.
Read MoreAdherence to airway clearance therapy in the home is crucial for managing chronic lung conditions, but challenges like time constraints and lack of perceived benefit can hinder patient compliance. Experts offer strategies and new technologies to help improve patients’ adherence.
Read MoreBaxter unveiled its next-generation Vest APX System, featuring patient-centered improvements for those with chronic lung conditions.
Read MoreBaxter Healthcare Corp recalls certain Volara system single-patient use circuits and blue ventilator adapter assemblies due to disconnection risk that may prevent proper ventilation.
Read MoreThe recall affects specific lots of the Volara system single-patient use circuit and blue ventilator adapter assembly due to a potential disconnection issue that could disrupt ventilation.
Read MoreBaxter Healthcare is recalling Life2000 ventilators due to potential charging failures caused by damage to the battery charger dongle.
Read MoreBaxter has expanded its US pharmaceuticals portfolio by launching five injectable drugs, including Vancomycin to treat infections of methicillin-resistant staphylococci.
Read MorePatient oxygen desaturation events can occur when the Life2000 ventilation system is connected with a third-party oxygen concentrator, the FDA says.
Read MoreThis article will present notable insights from a roundtable of pulmonologists who discuss potential solutions to improve treatment strategies for non-cystic fibrosis bronchiectasis patients.
Read MoreBaxter International Inc has issued an Urgent Medical Device Correction for the Hillrom Volara System (home care) over a possible risk of oxygen desaturation or barotrauma.
Read MoreBaxter has completed its acquisition of Hillrom for a cost of approximately $12.5 billion.
Read MoreMedical device company Baxter International Inc has entered into a definitive agreement to acquire Hillrom, according to the companies.
Read More